English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51992983    ???header.onlineuser??? :  802
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"liou j m"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 396-420 of 639  (26 Page(s) Totally)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-02-02T02:21:17Z Associations of circulating gut hormone and adipocytokine levels with the spectrum of gastroesophageal reflux disease Tseng P.-H.; Yang W.-S.; Liou J.-M.; Lee Y.-C.; Wang H.-P.; Lin J.-T.; MING-SHIANG WU
臺大學術典藏 2021-02-02T02:21:17Z Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; MING-SHIANG WU
臺大學術典藏 2021-02-02T02:21:15Z Prevention of gastric cancer by helicobacter pylori eradication: Current evidence and future prospects Liou J.-M.; Lin J.-T.; MING-SHIANG WU
臺大學術典藏 2021-02-02T02:21:15Z Mass eradication of helicobacter pylori to prevent gastric cancer: Theoretical and practical considerations Lee Y.-C.; Chiang T.-H.; Liou J.-M.; Chen H.-H.; MING-SHIANG WU; Graham D.Y.
臺大學術典藏 2021-02-02T02:21:15Z Statins and the risk of pancreatic cancer in Type 2 diabetic patients - A population-based cohort study Chen M.-J.; Tsan Y.-T.; Liou J.-M.; Lee Y.-C.; MING-SHIANG WU; Chiu H.-M.; Wang H.-P.; Chen P.-C.
臺大學術典藏 2021-02-02T02:21:14Z Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection Chen M.-J.; Liou J.-M.; Chen C.-C.; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; MING-SHIANG WU
臺大學術典藏 2021-02-02T02:21:14Z Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU
臺大學術典藏 2021-02-02T02:21:13Z letter: Could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment? Authors' reply Liou J.-M.; Chen M.-J.; MING-SHIANG WU
臺大學術典藏 2021-02-02T02:21:13Z Massive left pleural effusion after endoscopic variceal therapy Wu W.-K.; Wang H.-P.; Liou J.-M.; MING-SHIANG WU; Chen Y.-T.
臺大學術典藏 2021-02-02T02:21:10Z Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection Chen P.-Y.; MING-SHIANG WU; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-02-02T02:21:09Z Reply to Kim J.S. and Kim B.-W. Liou J.-M.; Chang C.-Y.; MING-SHIANG WU
臺大學術典藏 2021-02-02T02:21:08Z Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; the Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-02-02T02:21:08Z Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-02-02T02:21:07Z Treatment of Helicobacter pylori infection: Where are we now? Liou J.-M.; MING-SHIANG WU; Lin J.-T.
臺大學術典藏 2021-02-02T02:21:06Z Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL Kuo S.-H.; Chen L.-T.; Lin C.-W.; Yeh K.-H.; Shun C.-T.; Tzeng Y.-S.; Liou J.-M.; MING-SHIANG WU; Hsu P.-N.; Cheng A.-L.
臺大學術典藏 2021-02-02T02:21:06Z The Impact of Gastric Atrophy on the Incidence of Diabetes Yu T.-Y.; Wei J.-N.; Kuo C.-H.; Liou J.-M.; Lin M.-S.; Shih S.-R.; Hua C.-H.; Hsein Y.-C.; Hsu Y.-W.; Chuang L.-M.; Lee M.-K.; Hsiao C.-H.; MING-SHIANG WU; Li H.-Y.
臺大學術典藏 2021-02-02T02:21:06Z Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice? Liou J.-M.; Lin J.-T.; MING-SHIANG WU
臺大學術典藏 2021-02-02T02:21:05Z Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; MING-SHIANG WU
臺大學術典藏 2021-02-02T02:21:04Z letter: levofloxacin resistance – a challenge for treatment of Helicobacter pylori infection. Authors' reply Chen P.-Y.; MING-SHIANG WU; Liou J.-M.
臺大學術典藏 2021-02-02T02:21:03Z Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale Sheu B.-S.; MING-SHIANG WU; Chiu C.-T.; Lo J.-C.; Wu D.-C.; Liou J.-M.; Wu C.-Y.; Cheng H.-C.; Lee Y.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.
臺大學術典藏 2021-02-02T02:21:01Z Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials Chen M.-J.; MING-SHIANG WU; Chen C.-C.; Chen C.-C.; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏 2021-02-02T02:21:01Z Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis Kuo Y.-T.; Liou J.-M.; El-Omar E.M.; Wu J.-Y.; Leow A.H.R.; Goh K.L.; Das R.; Lu H.; Lin J.-T.; Tu Y.-K.; Yamaoka Y.; MING-SHIANG WU; for the, Asian Pacific Alliance on Helicobacter; Microbiota
臺大學術典藏 2021-02-02T02:21:00Z First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma Kuo S.-H.; Yeh K.-H.; MING-SHIANG WU; Lin C.-W.; Wei M.-F.; Liou J.-M.; Wang H.-P.; Chen L.-T.; Cheng A.-L.
臺大學術典藏 2021-02-02T02:20:59Z First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis Yeo Y.H.; Shiu S.-I.; Ho H.J.; Zou B.; Lin J.-T.; MING-SHIANG WU; Liou J.-M.; Wu C.-Y.
臺大學術典藏 2021-02-02T02:20:57Z Survey of the adherence to the consensus of gastroesophageal reflux disease before and after the implementation course Liou J.-M.; Sheu B.-S.; Lee Y.-C.; Cheng H.-C.; Chang W.-L.; Wu D.-C.; Hsu P.-I.; Wu C.-Y.; MING-SHIANG WU; Chiu C.-T.; Lin J.-T.

Showing items 396-420 of 639  (26 Page(s) Totally)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
View [10|25|50] records per page